10x Genomics, Inc. · NASDAQ:TXG
The Vanguard Group reported a 11.60% stake in 10x Genomics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 30, 2025
The Vanguard Group reported a 11.60% stake in 10x Genomics, Inc., 13,274,332 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G/A).
- Stake
- 11.60%
- Shares
- 13,274,332
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 11.60% | 13,274,332 |
Source
Related
- 10x Genomics, Inc.
- The Vanguard Group
- 10x Genomics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 25, 2026
- Schedule 13G/A · The Vanguard Group · Mar 24, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026